PubMed@dpavot:32876196_en_relations JSONTXT

Annnotations TAB JSON ListView MergeView

ENG_RE

Id Subject Object Predicate Lexical cue
T0 26-29 CHEBI_33697 denotes RNA
T1 54-60 HP_0012828 denotes severe
T2 61-66 HP_0011009 denotes acute
T3 79-86 DOID_4 denotes disease
T4 96-104 DOID_0080600 denotes COVID-19
T5 115-123 DOID_0080600 denotes COVID-19
T6 153-160 DOID_4 denotes disease
T7 181-187 HP_0012828 denotes severe
T8 248-257 GO_0009058 denotes synthesis
T9 383-391 DOID_0080600 denotes COVID-19
T10 593-601 DOID_0080600 denotes COVID-19
T11 1093-1101 CHEBI_16919 denotes creatine
T12 1202-1222 DOID_0080600 denotes SARS-CoV-2 infection
T13 1332-1340 DOID_0080600 denotes COVID-19
T14 1356-1361 HP_0011009 denotes acute
T15 1424-1444 DOID_0080600 denotes SARS-CoV-2 infection
R17 T15 T0 effect SARS-CoV-2 infection,RNA
R18 T15 T11 no_relation SARS-CoV-2 infection,creatine
R0 T8 T1 no_relation synthesis,severe
R1 T8 T7 no_relation synthesis,severe
R2 T8 T14 effect synthesis,acute
R3 T3 T0 effect disease,RNA
R4 T3 T11 effect disease,creatine
R5 T4 T0 no_relation COVID-19,RNA
R6 T4 T11 no_relation COVID-19,creatine
R7 T5 T0 no_relation COVID-19,RNA
R8 T5 T11 no_relation COVID-19,creatine
R9 T6 T0 no_relation disease,RNA
R10 T6 T11 no_relation disease,creatine
R11 T9 T0 effect COVID-19,RNA
R12 T10 T0 no_relation COVID-19,RNA
R13 T12 T0 effect SARS-CoV-2 infection,RNA
R14 T12 T11 no_relation SARS-CoV-2 infection,creatine
R15 T13 T0 effect COVID-19,RNA
R16 T13 T11 no_relation COVID-19,creatine

RELASIGEBLAH7hhaider5

Id Subject Object Predicate Lexical cue
T1 54-60 HP_0012828 denotes severe
T10 593-601 DOID_0080600 denotes COVID-19
T11 1093-1111 CHEBI_16919 denotes creatine kinase-MB
T12 1202-1222 DOID_0080600 denotes SARS-CoV-2 infection
T13 1332-1340 DOID_0080600 denotes COVID-19
T14 1356-1361 HP_0011009 denotes acute
T15 1424-1444 DOID_0080600 denotes SARS-CoV-2 infection
T2 61-66 HP_0011009 denotes acute
T3 67-86 DOID_4 denotes respiratory disease
T4 96-104 DOID_0080600 denotes COVID-19
T5 115-123 DOID_0080600 denotes COVID-19
T6 153-160 DOID_4 denotes disease
T7 181-187 HP_0012828 denotes severe
T8 248-257 GO_0009058 denotes synthesis
T9 383-391 DOID_0080600 denotes COVID-19
T16 26-35 DOID_0080600 denotes RNA virus
T17 0-10 DOID_0080600 denotes SARS-CoV-2
T18 143-160 DOID_0080600 denotes pulmonary disease
T19 1026-1044 DOID_0080600 denotes cardiac troponin I
T20 1009-1044 DOID_0080600 denotes high-sensitivity cardiac troponin I
T21 1046-1087 DOID_0080600 denotes N-terminal pro-B-type natriuretic peptide
T22 1117-1138 DOID_0080600 denotes cardiac complications
T23 1170-1183 DOID_0080600 denotes risk of death
T24 1160-1183 DOID_0080600 denotes increased risk of death
T25 958-994 DOID_0080600 denotes underlying cardiovascular conditions
R0 T8 T1 no_relation synthesis,severe
R1 T8 T7 no_relation synthesis,severe
R14 T12 T11 effect SARS-CoV-2 infection,creatine kinase-MB
R16 T13 T11 effect COVID-19,creatine kinase-MB
R18 T15 T11 effect SARS-CoV-2 infection,creatine kinase-MB
R2 T8 T14 no_relation synthesis,acute
R4 T3 T11 effect respiratory disease,creatine kinase-MB
R6 T4 T11 no_relation COVID-19,creatine kinase-MB
R19 T17 T16 effect SARS-CoV-2,RNA virus
R20 T17 T4 effect SARS-CoV-2,COVID-19
R21 T4 T3 effect COVID-19,respiratory disease
R22 T4 T18 effect COVID-19,pulmonary disease
R23 T4 T15 effect COVID-19,SARS-CoV-2 infection
R24 T16 T4 effect RNA virus,COVID-19
R25 T4 T20 effect COVID-19,high-sensitivity cardiac troponin I
R26 T4 T19 effect COVID-19,cardiac troponin I
R27 T4 T21 effect COVID-19,N-terminal pro-B-type natriuretic peptide
R28 T4 T11 effect COVID-19,creatine kinase-MB
R29 T4 T22 effect COVID-19,cardiac complications
R30 T20 T24 effect high-sensitivity cardiac troponin I,increased risk of death
R31 T20 T23 effect high-sensitivity cardiac troponin I,risk of death
R32 T19 T24 effect cardiac troponin I,increased risk of death
R33 T19 T23 effect cardiac troponin I,risk of death
R34 T21 T24 effect N-terminal pro-B-type natriuretic peptide,increased risk of death
R35 T21 T23 effect N-terminal pro-B-type natriuretic peptide,risk of death
R36 T11 T24 effect creatine kinase-MB,increased risk of death
R37 T11 T23 effect creatine kinase-MB,risk of death
R38 T22 T24 effect cardiac complications,increased risk of death
R39 T22 T23 effect cardiac complications,risk of death
R40 T18 T11 effect pulmonary disease,creatine kinase-MB
R41 T18 T20 effect pulmonary disease,high-sensitivity cardiac troponin I
R42 T18 T19 effect pulmonary disease,cardiac troponin I
R43 T18 T21 effect pulmonary disease,N-terminal pro-B-type natriuretic peptide
R44 T18 T11 effect pulmonary disease,creatine kinase-MB
R45 T18 T22 effect pulmonary disease,cardiac complications
R46 T18 T24 effect pulmonary disease,increased risk of death
R47 T18 T23 effect pulmonary disease,risk of death
R48 T25 T24 effect underlying cardiovascular conditions,increased risk of death
R49 T25 T23 effect underlying cardiovascular conditions,risk of death

ENG_RE_Diana

Id Subject Object Predicate Lexical cue
T0 26-29 CHEBI_33697 denotes RNA
T1 54-60 HP_0012828 denotes severe
T10 593-601 DOID_0080600 denotes COVID-19
T11 1093-1101 CHEBI_16919 denotes creatine
T12 1202-1222 DOID_0080600 denotes SARS-CoV-2 infection
T13 1332-1340 DOID_0080600 denotes COVID-19
T14 1356-1361 HP_0011009 denotes acute
T15 1424-1444 DOID_0080600 denotes SARS-CoV-2 infection
T2 61-66 HP_0011009 denotes acute
T3 79-86 DOID_4 denotes disease
T4 96-104 DOID_0080600 denotes COVID-19
T5 115-123 DOID_0080600 denotes COVID-19
T6 153-160 DOID_4 denotes disease
T7 181-187 HP_0012828 denotes severe
T9 383-391 DOID_0080600 denotes COVID-19
R10 T6 T11 no_relation disease,creatine
R11 T9 T0 effect COVID-19,RNA
R12 T10 T0 no_relation COVID-19,RNA
R13 T12 T0 effect SARS-CoV-2 infection,RNA
R14 T12 T11 effect SARS-CoV-2 infection,creatine
R15 T13 T0 effect COVID-19,RNA
R16 T13 T11 effect COVID-19,creatine
R17 T15 T0 effect SARS-CoV-2 infection,RNA
R18 T15 T11 effect SARS-CoV-2 infection,creatine
R3 T3 T0 effect disease,RNA
R4 T3 T11 effect disease,creatine
R5 T4 T0 effect COVID-19,RNA
R6 T4 T11 effect COVID-19,creatine
R7 T5 T0 no_relation COVID-19,RNA
R8 T5 T11 effect COVID-19,creatine
R9 T6 T0 no_relation disease,RNA
R19 T14 T15 effect acute,SARS-CoV-2 infection

ENG_RE_pruas

Id Subject Object Predicate Lexical cue
T0 26-29 CHEBI_33697 denotes RNA
T1 54-60 HP_0012828 denotes severe
T10 593-601 DOID_0080600 denotes COVID-19
T11 1093-1101 CHEBI_16919 denotes creatine
T12 1202-1222 DOID_0080600 denotes SARS-CoV-2 infection
T13 1332-1340 DOID_0080600 denotes COVID-19
T14 1356-1361 HP_0011009 denotes acute
T15 1424-1444 DOID_0080600 denotes SARS-CoV-2 infection
T2 61-66 HP_0011009 denotes acute
T5 115-123 DOID_0080600 denotes COVID-19
T7 181-187 HP_0012828 denotes severe
T9 383-391 DOID_0080600 denotes COVID-19
T4 96-104 DOID_0080600 denotes COVID-19
T16 67-86 DOID_1579 denotes respiratory disease
T17 67-86 HP_0002795 denotes respiratory disease
T18 96-104 HP_0033141 denotes COVID-19
T19 115-123 HP_0033141 denotes COVID-19
T20 143-160 DOID_850 denotes pulmonary disease
T21 143-160 HP_0002795 denotes pulmonary disease
T22 188-209 HP_0001626 denotes cardiovascular damage
T23 276-293 HP_0001637 denotes myocardial injury
T24 383-391 HP_0033141 denotes COVID-19
T25 1068-1087 CHEBI_80233 denotes natriuretic peptide
T26 1202-1222 HP_0033141 denotes SARS-CoV-2 infection
T27 593-601 HP_0033141 denotes COVID-19
T28 1332-1340 HP_0033141 denotes COVID-19
T29 1424-1444 HP_0033141 denotes SARS-CoV-2 infection
T30 1362-1391 HP_0030872 denotes cardiovascular decompensation
R11 T9 T0 effect COVID-19,RNA
R14 T12 T11 effect SARS-CoV-2 infection,creatine
R16 T13 T11 no_relation COVID-19,creatine
R18 T15 T11 effect SARS-CoV-2 infection,creatine
R7 T5 T0 no_relation COVID-19,RNA
R5 T4 T0 no_relation COVID-19,RNA
R19 T2 T17 effect acute,respiratory disease
R20 T1 T17 effect severe,respiratory disease
R21 T1 T16 effect severe,respiratory disease
R22 T2 T16 effect acute,respiratory disease
R23 T7 T22 effect severe,cardiovascular damage
R24 T19 T22 effect COVID-19,cardiovascular damage
R25 T5 T22 effect COVID-19,cardiovascular damage
R26 T18 T22 effect COVID-19,cardiovascular damage
R27 T4 T22 effect COVID-19,cardiovascular damage
R28 T24 T23 effect COVID-19,myocardial injury
R29 T9 T23 effect COVID-19,myocardial injury
R30 T26 T11 effect SARS-CoV-2 infection,creatine
R31 T29 T11 effect SARS-CoV-2 infection,creatine
R32 T28 T11 effect COVID-19,creatine
R33 T13 T25 effect COVID-19,natriuretic peptide
R34 T28 T25 effect COVID-19,natriuretic peptide
R35 T12 T25 effect SARS-CoV-2 infection,natriuretic peptide
R36 T26 T15 effect SARS-CoV-2 infection,SARS-CoV-2 infection
R37 T29 T25 effect SARS-CoV-2 infection,natriuretic peptide
R38 T28 T30 effect COVID-19,cardiovascular decompensation
R39 T13 T30 effect COVID-19,cardiovascular decompensation
R40 T14 T30 effect acute,cardiovascular decompensation

ENG_RE_mabarros

Id Subject Object Predicate Lexical cue
T0 26-29 CHEBI_33697 denotes RNA
T1 54-60 HP_0012828 denotes severe
T10 593-601 DOID_0080600 denotes COVID-19
T11 1093-1101 CHEBI_16919 denotes creatine
T12 1202-1222 DOID_0080600 denotes SARS-CoV-2 infection
T13 1332-1340 DOID_0080600 denotes COVID-19
T14 1356-1361 HP_0011009 denotes acute
T15 1424-1444 DOID_0080600 denotes SARS-CoV-2 infection
T2 61-66 HP_0011009 denotes acute
T3 79-86 DOID_4 denotes disease
T4 96-104 DOID_0080600 denotes COVID-19
T5 115-123 DOID_0080600 denotes COVID-19
T6 153-160 DOID_4 denotes disease
T7 181-187 HP_0012828 denotes severe
T9 383-391 DOID_0080600 denotes COVID-19
R7 T5 T0 no_relation COVID-19,RNA
R8 T5 T11 no_relation COVID-19,creatine
R9 T6 T0 no_relation disease,RNA
R10 T6 T11 no_relation disease,creatine
R11 T9 T0 effect COVID-19,RNA
R12 T10 T0 no_relation COVID-19,RNA
R13 T12 T0 effect SARS-CoV-2 infection,RNA
R14 T12 T11 no_relation SARS-CoV-2 infection,creatine
R15 T13 T0 effect COVID-19,RNA
R16 T13 T11 no_relation COVID-19,creatine
R17 T15 T0 effect SARS-CoV-2 infection,RNA
R18 T15 T11 no_relation SARS-CoV-2 infection,creatine
R4 T3 T11 effect disease,creatine
R5 T4 T0 no_relation COVID-19,RNA
R6 T4 T11 no_relation COVID-19,creatine